Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 786.23 USD -3.15% Market Closed
Market Cap: 747.3B USD
Have any thoughts about
Eli Lilly and Co?
Write Note

Eli Lilly and Co
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eli Lilly and Co
Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
ZTS

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Eli Lilly and Co
NYSE:LLY
Long-Term Debt
$29B
CAGR 3-Years
23%
CAGR 5-Years
16%
CAGR 10-Years
19%
Johnson & Johnson
NYSE:JNJ
Long-Term Debt
$31.3B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
9%
Bristol-Myers Squibb Co
NYSE:BMY
Long-Term Debt
$48.7B
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
21%
Pfizer Inc
NYSE:PFE
Long-Term Debt
$57.5B
CAGR 3-Years
17%
CAGR 5-Years
10%
CAGR 10-Years
6%
Merck & Co Inc
NYSE:MRK
Long-Term Debt
$35B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
7%
Zoetis Inc
NYSE:ZTS
Long-Term Debt
$6.6B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
6%

See Also

What is Eli Lilly and Co's Long-Term Debt?
Long-Term Debt
29B USD

Based on the financial report for Sep 30, 2024, Eli Lilly and Co's Long-Term Debt amounts to 29B USD.

What is Eli Lilly and Co's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
19%

Over the last year, the Long-Term Debt growth was 62%. The average annual Long-Term Debt growth rates for Eli Lilly and Co have been 23% over the past three years , 16% over the past five years , and 19% over the past ten years .

Back to Top